GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jiangsu Lianhuan Pharmaceutical Co Ltd (SHSE:600513) » Definitions » Cyclically Adjusted Revenue per Share

Jiangsu Lianhuan Pharmaceutical Co (SHSE:600513) Cyclically Adjusted Revenue per Share : ¥5.06 (As of Mar. 2025)


View and export this data going back to 2003. Start your Free Trial

What is Jiangsu Lianhuan Pharmaceutical Co Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Jiangsu Lianhuan Pharmaceutical Co's adjusted revenue per share for the three months ended in Mar. 2025 was ¥2.178. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ¥5.06 for the trailing ten years ended in Mar. 2025.

During the past 12 months, Jiangsu Lianhuan Pharmaceutical Co's average Cyclically Adjusted Revenue Growth Rate was 10.70% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 12.10% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 12.80% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 13.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Jiangsu Lianhuan Pharmaceutical Co was 15.00% per year. The lowest was 10.80% per year. And the median was 13.60% per year.

As of today (2025-05-19), Jiangsu Lianhuan Pharmaceutical Co's current stock price is ¥9.39. Jiangsu Lianhuan Pharmaceutical Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was ¥5.06. Jiangsu Lianhuan Pharmaceutical Co's Cyclically Adjusted PS Ratio of today is 1.86.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Jiangsu Lianhuan Pharmaceutical Co was 15.70. The lowest was 1.69. And the median was 2.96.


Jiangsu Lianhuan Pharmaceutical Co Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Jiangsu Lianhuan Pharmaceutical Co's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jiangsu Lianhuan Pharmaceutical Co Cyclically Adjusted Revenue per Share Chart

Jiangsu Lianhuan Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.05 3.48 3.98 4.45 4.90

Jiangsu Lianhuan Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.57 4.69 4.83 4.90 5.06

Competitive Comparison of Jiangsu Lianhuan Pharmaceutical Co's Cyclically Adjusted Revenue per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Jiangsu Lianhuan Pharmaceutical Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jiangsu Lianhuan Pharmaceutical Co's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jiangsu Lianhuan Pharmaceutical Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Jiangsu Lianhuan Pharmaceutical Co's Cyclically Adjusted PS Ratio falls into.


;
;

Jiangsu Lianhuan Pharmaceutical Co Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Jiangsu Lianhuan Pharmaceutical Co's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=2.178/115.1156*115.1156
=2.178

Current CPI (Mar. 2025) = 115.1156.

Jiangsu Lianhuan Pharmaceutical Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 0.524 99.500 0.606
201509 0.741 100.500 0.849
201512 0.547 100.600 0.626
201603 0.580 102.200 0.653
201606 0.485 101.400 0.551
201609 0.584 102.400 0.657
201612 0.478 102.600 0.536
201703 0.507 103.200 0.566
201706 0.495 103.100 0.553
201709 0.620 104.100 0.686
201712 0.721 104.500 0.794
201803 0.852 105.300 0.931
201806 0.826 104.900 0.906
201809 0.876 106.600 0.946
201812 1.041 106.500 1.125
201903 0.885 107.700 0.946
201906 0.986 107.700 1.054
201909 1.144 109.800 1.199
201912 1.357 111.200 1.405
202003 1.069 112.300 1.096
202006 1.115 110.400 1.163
202009 1.218 111.700 1.255
202012 1.473 111.500 1.521
202103 1.175 112.662 1.201
202106 1.473 111.769 1.517
202109 1.431 112.215 1.468
202112 1.642 113.108 1.671
202203 1.463 114.335 1.473
202206 1.672 114.558 1.680
202209 1.841 115.339 1.837
202212 1.882 115.116 1.882
202303 1.597 115.116 1.597
202306 1.660 114.558 1.668
202309 1.931 115.339 1.927
202312 2.388 114.781 2.395
202403 1.786 115.227 1.784
202406 2.167 114.781 2.173
202409 1.743 115.785 1.733
202412 1.768 114.893 1.771
202503 2.178 115.116 2.178

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Jiangsu Lianhuan Pharmaceutical Co  (SHSE:600513) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Jiangsu Lianhuan Pharmaceutical Co's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=9.39/5.06
=1.86

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Jiangsu Lianhuan Pharmaceutical Co was 15.70. The lowest was 1.69. And the median was 2.96.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Jiangsu Lianhuan Pharmaceutical Co Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Jiangsu Lianhuan Pharmaceutical Co's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Jiangsu Lianhuan Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 9, Jiankang 1st Road, Yangzhou Bio-Health Industry Park, Jiangsu Province, Yangzhou, Jiangsu, CHN, 225127
Jiangsu Lianhuan Pharmaceutical Co Ltd is engaged in producing benign prostatic hyperplasia, allergy and cardiovascular drugs. In the field of pharmaceutical manufacturing, the company's main products include several series such as urinary system drugs, antihistamines, cardiovascular drugs, steroid hormones, antibiotics, etc., covering chemical raw materials and injections, solid preparations and various drug dosage forms, including the national first-class new drug Apelite Tablets (Chuanliu).
Executives
Wang Chun Yuan Supervisors
Chu Qing Song senior management
Xia Chun Lai Director
Pan He Ping Directors, senior managers
Niu Ben senior management
Wu Wen Ge Director
Zhu Yong Jun senior management
Qian Zhen Hua Director
Shen Yi senior management
Huang Wen Tao senior management
Zhou Jun senior management
Tu Bin senior management
Qin Xiong Jian senior management

Jiangsu Lianhuan Pharmaceutical Co Headlines

No Headlines